Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3062]
News [6217]
Articles [124]
Editorials [18]
Conferences [183]
elearning [32]
Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients
Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients
3D-patient tumour avatars: Maximising their potential for next-generation precision oncology
3D-patient tumour avatars: Maximising their potential for next-generation precision oncology
Why do many young cancer survivors forgo human papillomavirus vaccination?
Why do many young cancer survivors forgo human papillomavirus vaccination?
Bioengineered synthetic gene circuits enhance cancer immunotherapies
Bioengineered synthetic gene circuits enhance cancer immunotherapies
A double bind for cancer
A double bind for cancer
ASH 2022: Blinatumomab further improves survival among B-lineage ALL patients with a good prognosis
ASH 2022: Blinatumomab further improves survival among B-lineage ALL patients with a good prognosis
ASH 2022: Next-generation targeted therapy zanubrutinib found superior to ibrutinib for CLL and SLL
ASH 2022: Next-generation targeted therapy zanubrutinib found superior to ibrutinib for CLL and SLL
FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC
FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC
ASH 2022: MajesTEC-2 trial of teclistamab-cqyv in combination with daratumumab and hyaluronidase-fihj and lenalidomide shows clinical activity in RRMM
ASH 2022: MajesTEC-2 trial of teclistamab-cqyv in combination with daratumumab and hyaluronidase-fihj and...
Palbociclib combination in advanced breast cancer: Again only disadvantages
Palbociclib combination in advanced breast cancer: Again only disadvantages

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation